RANDALL NGUYEN, MD
Ophthalmology Physician · LONG BEACH, CA
Individual Active NPI 1750382008
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,407 | 62,796 | $7,295,062 | $4,164,370 | $3,250,999 |
| 2023 | 1,520 | 57,971 | $6,477,104 | $3,904,369 | $3,043,681 |
| 2022 | 1,506 | 29,126 | $6,983,140 | $4,151,237 | $3,234,793 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 47,580 | $35 | $28 |
| 92134 | Imaging of retina | 3,377 | $45 | $32 |
| 67028 | Injection of drug into eye | 1,779 | $134 | $100 |
| 92012 | Established patient problem focused exam of visual system | 1,317 | $99 | $70 |
| 92014 | Established patient complete exam of visual system | 1,265 | $139 | $94 |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 1,144 | $16 | $12 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 1,126 | $223 | $178 |
| J2778 | Injection, ranibizumab, 0.1 mg | 929 | $163 | $129 |
| J0178 | Injection, aflibercept, 1 mg | 786 | $824 | $656 |
| J0177 | Injection, aflibercept hd, 1 mg | 784 | $331 | $264 |
| J7999 | Compounded drug, not otherwise classified | 240 | $93 | $72 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 154 | $27 | $18 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | A55189 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in California
- NPI 1992720023
- NPI 1528241775
- NPI 1013073295
- NPI 1871513168
- NPI 1134188519
- NPI 1538137666
- NPI 1629052527
- NPI 1710093083
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.